Screener
Eligibility screening
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
1 US site in CA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.